In recent trading, shares of Ericsson (Symbol: ERIC) have crossed above the average analyst 12-month target price of $11.18, changing hands for $11.58/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation,

格隆汇7月10日｜据美国方面消息，尽管伊朗多次要求船舶改走靠近伊朗海岸的北部航道，美国海军仍继续建议商业船只使用霍尔木兹海峡南部航道。设于巴林的联合海事情报中心（Joint Maritime Information Center，JMIC）当天发布通告称，霍尔木兹海峡及周边水域的安全威胁等级仍处于严重水平，但强调海峡南部航道已经扩展，并继续向所有船只开放。通告建议船只通过霍尔木兹海峡时与联合海军部队进行协调，但同时指出，这并非强制要求，船舶也可以在不协调的情况下通过南部航道。

This week's dividend activity included increased payouts from PNC Financial ( PNC ) and CF Industries ( CF ) as well as declarations from Costco ( COST ) and Phillips 66 ( PSX ). Additionally, looking towards next week, industry players such as Abbott Labs ( ABT ) and AbbVie ( ABBV ) will see the ex-dividend dates for their upcoming dividend payments. See a breakdown below of some of the highlights of this week, along with some upcoming activity on the dividend front. Dividend Increases Here are some companies that have announced a dividend increase in the past week: PNC Financial ( PNC ) Dividend declared: July 6 New dividend amount: $2.00 Previous amount: $1.70 Increase: 17.6% Marsh & McLennan ( MRSH ) Dividend declared: July 8 New dividend amount: $0.99 Previous amount: $0.90 Increase: 10% CF Industries ( CF ) Dividend declared: July 8 New dividend amount: $0.60 Previous amount: $0.50 Increase: 20% Dividend Declarations Here are some companies that have announced a dividend in the past week: MetLife ( MET ) Dividend declared: July 7 Dividend amount: $0.5925 Costco ( COST ) Dividend declared: July 8 Dividend amount: $1.47 Carnival ( CCL ) Dividend declared: July 9 Dividend amount: $0.15 Phillips 66 ( PSX ) Dividend declared: July 9 Dividend amount: $0.27 Upcoming Dividend Calendar Here are some companies that have an ex-dividend date coming next week: Pershing Square ( PS ) Ex-dividend date: July 13 Payout date: July 21 Abbott Labs ( ABT ) Ex-dividend date: July 15 Payout date: Aug. 17 AbbVie ( ABBV ) Ex-dividend date: July 15 Payout date: Aug. 14 Williams-Sonoma ( WSM ) Ex-dividend date: July 17 Payout date: Aug. 21 Additional Dividend Information For investors looking to gain further access to the dividend space, listed below are some popular dividend-focused ETFs that can be further analyzed: Dividend ETFs: ( VIG ), ( SCHD ), ( VYM ), ( DGRO ), ( SDY ), ( DVY ), ( IDV ), ( DGRW ), ( NOBL ), ( HDV ), ( RDVY ), ( VIGI ), and ( SDVY ). More on markets 25 stocks up...

Retained executive search firm Caldwell ( CWLPF ) said on Friday that it has appointed John Blank as chief operating officer. He will oversee the firm's global operations while continuing to serve clients as a managing partner in Caldwell's Life Sciences & Healthcare Practice. The firm also announced the establishment of a new regional managing partner structure designed to support the firm's continued growth, strengthen operational effectiveness, and enhance coordination across its global platform. As part of this leadership structure, Peter Reed has been named regional managing partner, United States; Drew Railton has been named regional managing partner, Canada; Alex Alcott has been named regional managing partner, Europe; and Rob Wilder has been named regional managing partner, Middle East & North Africa. Source: Press Release More on The Caldwell Partners International Inc. Dividend scorecard for The Caldwell Partners International Inc. Financial information for The Caldwell Partners International Inc.

AI到底给云厂商带来了什么？是云计算终于迎来了新一轮增长，还是云厂商换了一套讲增长的语言？如果增长已经发生，它究竟来自哪里？ 2026年过半，中国云计算行业的叙事逻辑开始发生变化。 仔细观察各大云厂商近期在各种公开场合的语境，可以发现大家极有默契地减少了对传统TOB算力增长的单一描绘，取而代之的是各种新概念的频频亮相。 具体来看，2026年一季度，阿里云AI相关产品连续11个季度三位数增长，占外部商业化收入首超30%；百度AI云GPU云暴涨184%；腾讯企业服务收入+20%，管理层明确归因于"AI需求带动GPU、CPU、存储资源"；火山引擎中国公有云上大模型调用量同比增长16倍。 很明显，今年上半年，无论是阿里云、百度智能云，还是火山引擎，对外披露的重点都开始转向AI相关指标，比如AI云收入、MaaS、模型调用、GPU算力、Token消耗、Agent平台。 AI，已经成为发布会和财报电话会上的主角。 这些变化看似只是财报口径调整，却提出了一个新的问题。那就是AI到底给云厂商带来了什么？是云计算终于迎来了新一轮增长，还是云厂商换了一套讲增长的语言？如果增长已经发生，它究竟来自哪里？ 从GPU到Token，云厂商切换增长指标 回看过去十余年中国云计算黄金时代，行业底层逻辑几乎完全建立在CPU通用计算之上。传统TOB业务主要围绕vCPU核数、内存容量和存储带宽计费，资源消耗评估也长期采用这套指标体系。 这套模式类似“出租地产”。云厂商提供计算、存储和网络资源，企业按实际使用规模付费。客户开通越多虚拟机、挂载越大硬盘容量，云厂商收入增长越快。 随着火山引擎、阿里云等头部厂商在财报和发布会上频繁强调“AI云”与“MaaS”，云计算资源衡量口径开始发生变化。过去看CPU核数，如今看GPU占用率，进入应用层后，则进一步转化为Token调用量。 IDC最新全景报告显示，2025年中国公有云大模型调用量已达1944万亿Tokens。IDC预计，2026年全年中国MaaS市场Token消耗量将升至约40000万亿次。如此增长速度，在以CPU核数衡量资源消耗阶段几乎无法想象。 具体到企业样本来看，这种由“Token”主导的增量表现得更为具象和激进。 在2026年6月的夏季Force原动力大会上，火山引擎高调披露其豆包大模型日均Token调用量已经一举突破180万亿，在过去短短一年时间里实...

据路透社10日消息，有知情人士透露，卡塔尔谈判代表已抵达伊朗，将与伊方官员会面，以缓和紧张局势并为谈判的持续创造条件，此轮会谈系与美国协调进行。消息称，此轮会谈旨在讨论美伊谅解备忘录的执行情况，以及近期引发局势升级的问题，包括霍尔木兹海峡航行争议。截至目前，美伊官方与卡塔尔方面暂未证实相关内容。（央视新闻）

In recent trading, shares of Starbucks Corp. (Symbol: SBUX) have crossed above the average analyst 12-month target price of $106.00, changing hands for $106.41/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on va

In recent trading, shares of KLA Corp (Symbol: KLAC) have crossed above the average analyst 12-month target price of $224.28, changing hands for $229.49/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation

格隆汇7月10日｜紫光股份公告，预计2026年上半年净利润为19.1亿元-23.2亿元，同比增长83.50%-122.89%。公司预计2026年1-6月归属于上市公司股东的净利润较上年同期大幅增长，主要原因是公司在人工智能算力需求爆发的强劲驱动下，2026年上半年ICT市场继续保持快速增长，公司积极把握智算和国产化领域带来的市场机遇，持续深耕行业市场，加快产品研发和技术创新，强化供应链精细化管理和运作以保障供给的稳定与交付的连续，从而推动公司营业收入实现快速增长，带动了毛利水平的持续提升。

SK Hynix ADRs Priced At 3% Premium As Wall Street Readies Wave Of Leveraged ETFs The next test of the AI trade arrives today, as South Korean memory-chip maker SK Hynix's American depositary receipts begin trading under the temporary ticker SKHYV. Shares were priced at about a 3% premium to Thursday's close of its ordinary shares in South Korea. The $26.5 billion offering attracted demand for roughly seven times the shares available, forcing the chipmaker to scale back allocations to major investors, according to Bloomberg . The company sold 177.9 million ADRs at $149 each, raising $26.5 billion, surpassing Alibaba's US debut to become the third-largest listing in history. Each ADR represents one-tenth of a Seoul-listed common share, giving US investors direct exposure to the world's leading supplier of high-bandwidth memory amid the AI boom that could soon unlock the Physical AI boom. According to the report, Baillie Gifford, Coatue Management, and Situational Awareness Partners received about $5 billion of ADRs, roughly $2 billion less than indicated. Over 500 institutional investors placed orders, including long-only funds, technology specialists, and sovereign wealth funds. The allocation remained concentrated, with 10 investors taking half the deal and the top 25 accounting for about two-thirds. Wall Street analysts weighed in with their first takes of the deal, courtesy of Bloomberg: Jung In Yun, CEO at Fibonacci Asset Management "I take 3% premium as a constructive signal. It shows that global investors are still willing to pay up for direct US access despite the recent volatility in Korean equities" From the company's and banks' perspective, the level looks sensible; it is strong enough to demonstrate demand, but not so aggressive that it creates unnecessary aftermarket risk In the current market, a clean, stable debut matters more than squeezing out the last few percentage points of valuation Sanghyun Park, founder of Clepsydra Capital It shows global funds...

Key PointsCoca-Cola is hovering around an all-time high.

Morsa Images/DigitalVision via Getty Images I believe there is upside in Forte Biosciences ( FBRX ) because I think investors are viewing this company through the wrong lens. The common perception of Forte Biosciences is that it's a small-cap, single-asset biotech with one binary celiac disease readout for its celiac disease drug candidate (FB102). What makes Forte attractive to me is that in addition to showing activity in celiac disease using the same CD122 targeting mechanism used to show placebo-controlled activity in another tissue compartment (vitiligo), the company may have broader potential. Forte's strategy for FB102 is to target CD122 within interleukin-2 (IL-2) and interleukin-15 (IL-15) receptor biology, which relates directly to natural killer (NK) cells and certain pathogenic T-cell subsets. Using both in vitro studies and nonhuman primates, Forte demonstrated meaningful suppression of NK cell pharmacodynamic markers with preservation of regulatory T-cells, which would be very important if they could replicate these results clinically. To me, the bull case is that FB102 suppresses inflammation in one disease, but also potentially modulates a broader recurrent autoimmune circuit seen in gut, skin, and hair follicles. Cash and Runway Compared to the R&D expense of $12.7 million in Q1-2025, the company incurred R&D expense of $20.5 million during the comparable period in Q1-2026. This increase in R&D expense is primarily due to increased clinical expenses associated with the Phase II celiac disease trial and Phase Ib trials for vitiligo and alopecia areata. G&A decreased from $3.4 million in Q1-2025 to $2.0 million in Q1-2026 as the prior year included a significant amount of legal settlement related expenses. Overall, Forte had a net loss of $22.1 million or $1.24 per share in Q1-2026. As of March 31, 2026, Forte had cash on hand and in cash equivalents totaling $58.2 million; however, that does not accurately reflect the company's current funding positi...

启明星辰公告，预计2026年1月1日至2026年6月30日营业收入12.1亿元至12.6亿元，比上年同期增长6.84%至11.25%。归属于上市公司股东的净利润2600万元至3800万元，上年同期为亏损9335万元。扣除非经常性损益后的净利润5500万元至6700万元，上年同期为亏损1.64亿元。基本每股收益0.021元/股至0.031元/股，上年同期为亏损0.0767元/股。

华茂股份公告，预计2026年1月1日至2026年6月30日归属于上市公司股东的净亏损为1000万元-2000万元，上年同期为盈利9650.48万元。扣除非经常性损益后的净利润为盈利5000万元-7000万元，上年同期为盈利2635.13万元，比上年同期增长89.74%-165.64%。基本每股收益亏损0.011元/股-0.022元/股，上年同期为盈利0.106元/股。

紫光股份公告，预计2026年上半年净利润为19.1亿元-23.2亿元，同比增长83.50%-122.89%。公司预计2026年1-6月归属于上市公司股东的净利润较上年同期大幅增长，主要原因是公司在人工智能算力需求爆发的强劲驱动下，2026年上半年ICT市场继续保持快速增长，公司积极把握智算和国产化领域带来的市场机遇，持续深耕行业市场，加快产品研发和技术创新，强化供应链精细化管理和运作以保障供给的稳定与交付的连续，从而推动公司营业收入实现快速增长，带动了毛利水平的持续提升。

JHVEPhoto/iStock Editorial via Getty Images After the market closed on July 9th, the management team at Aritzia ( ATZAF ) announced financial results covering the first quarter of the company's 2027 fiscal year. Compared to what analysts anticipated, it was actually a very good quarter. Revenue and earnings per share came in above expectations, while adjusted earnings per share did the same. Management reported a year-over-year increase in the number of boutiques that the institution has in operation, and they also reported a surge in comparable sales. To be honest with you, this is the perfect recipe for investors to see. But then when you add on top of this a strong balance sheet and a history of growth leading up to this point, we end up with a business that is clearly high quality. Unfortunately, this does not necessarily translate to it being an attractive investment. Back in December of 2023, I pointed out how the Canadian fashion house was an interesting play for those interested in ‘everyday luxury.’ But ultimately, I viewed the business as less appealing than the market did simply because growth was slowing, costs were rising, and the stock was not quite as cheap as I would have liked it to have been. To be honest with you, this was a misjudgment. The stock has skyrocketed 417.3% since then, handily outperforming the 59.4% rise that the S&P 500 saw. Looking back, I would have been wise to take a bullish stance on the institution. And now, as much as I would love to, it is too late. I wouldn't go so far as to say that this is now a bearish prospect. After all, growth is still phenomenal. But I would argue that the stock is more expensive than I am comfortable with. Not to the point of rating it a ‘sell,’ but certainly to the point of keeping it as a ‘hold.’ A necessary disclosure As a Canadian company, Aritzia reports its financial results in Canadian dollars. I, on the other hand, think about things in U.S. dollars. I would imagine that most of my readers d...

Here are the biggest calls on Wall Street on Friday: DA Davidson initiates Agco as buy DA says the ag equipment company has "earnings leverage." "We are initiating coverage of AGCO with a BUY rating and $160 price target." Wells Fargo initiates X4 Pharmaceuticals as overweight The firm said in its initiation of X4 that the Street is underestimating the probability of success of the company's trial of its immune deficiency drug. "We believe Street's POS [probability of success] is too low for mavorixafor's Ph3 in chronic neutropenia (CN) creating a favorable skew ahead of the 2H27 readout." Wells Fargo upgrades Seagate to overweight from equal weight Wells says investors should buy the dip. "With the recent market pullback and increasing confidence in what we view as a path to +$50 EPS + significant cap return capacity ahead, we upgrade STX to OW w/ a $1,100 PT (~20x CY28 P/E; was $900)." Morgan Stanley reiterates SpaceX as overweight Morgan Stanley says the release of Grok 4.5 is an important catalyst for SpaceX. "Key question remains whether SpaceXAI will be able to combine Grok + Cursor to create compelling, differentiated enterprise products that aren't easily replicated by competing labs." Morgan Stanley reiterates Nvidia as overweight Morgan Stanley says the stock remains a top idea following a meeting with management. "This week, we hosted a number of investor meetings in California as part of an NDR with Nvidia CEO Jensen Huang, CFO Colette Kress, and head of IR Toshiya Hari. The meetings were upbeat, as expected, with the company describing "accelerating growth rates" even as revenues approach the $100 bn per quarter mark." Raymond James initiates BrightSpring as outperform Raymond James says the healthcare company has a differentiated offering. "We are initiating coverage of BrightSpring Health Services (BTSG) with an Outperform rating and an $80 price target." Bernstein upgrades J.B. Hunt to outperform from market perform The firm says it's not too late to...

Steven Cook, Council on Foreign Relations Middle East Senior Fellow, says it's unclear how President Donald Trump will "finish the job" in Iran. But Cook says Trump does not want to see a return to all out combat. Cook speaks on "Bloomberg Surveillance." (Source: Bloomberg)

Fasai Budkaew/iStock via Getty Images In today's article, we return to one of our favorite companies: Affiliated Managers Group, Inc. ( AMG ). AMG's common stock is currently trading almost 30% higher than at the beginning of the year, and the baby bonds, which are trading below par, offer a yield to maturity of close to 7.8%, an investment-grade credit rating, and 16% capital appreciation potential. Let's take a closer look at the following lines, and if you want to follow what happened to the company in the previous quarter, you can do so here . Overview AMG was founded in 1993 in Boston, Massachusetts. At the end of the first quarter, the company had close to $9.4 billion in total assets and a total debt of around $3.12 billion. The total equity of the company is approximately $4.25 billion. The current market capitalization is close to $9.4 billion. The company falls into the "investment-grade" category with its credit ratings from the major credit agencies, pictured below: AMG's presentation (amg.com) The company's 5-year total return is close to 15.61%, and the 10-year total return is close to 10.26%: AMG's total returns (morningstar.com) AMG outperforms its peers by total return, as you can see in the 5-year total return comparison below: 5-year total return comparison with peers (seekingalpha.com) A quite similar situation, with the 5-year total return comparison with the overall market, for the last few months: AMG vs SP500 (seekingalpha.com) The common stock is currently at a price of $364.96, which is 27% higher than the price at the beginning of 2026 and close to 80% higher than its price a year ago. AMG's common stock (seekingalpha.com) We are not а such fans of the common stocks, since the company has safety baby bonds, which are more advantageous, but the steady rise of the common stock's price adds additional security to the bonds. We follow the rule that it is always good to buy bonds of the company when its common stock performs well. The market gi...

Key PointsGE Vernova dominates the power infrastructure market, supporting nearly 25% of the world's electricity generation.

Desde elegir el momento para ir al parque hasta tomar duchas frías, criar hijos en Madrid ofrece un adelanto de cómo el cambio climático está transformando la vida familiar en toda Europa. (Source: Bloomberg)

In recent trading, shares of Qiagen NV (Symbol: QGEN) have crossed above the average analyst 12-month target price of $41.47, changing hands for $41.99/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation,